In Silico Development of Novel Benzofuran-1,3,4-Oxadiazoles as Lead Inhibitors of <i>M. tuberculosis</i> Polyketide Synthase 13

In Silico Development of Novel Benzofuran-1,3,4-Oxadiazoles as Lead Inhibitors of <i>M. tuberculosis</i> Polyketide Synthase 13

Benzofuran and 1,3,4-oxadiazole are privileged and versatile heterocyclic pharmacophores which display a broad spectrum of biological and pharmacological therapeutic potential against a wide variety of diseases. This article reports in silico CADD (computer-aided drug design) and molecular hybridiza...

Full description

Bibliographic Details
Main Authors: Ali Irfan, Shah Faisal, Ameer Fawad Zahoor, Razia Noreen, Sami A. Al-Hussain, Burak Tuzun, Rakshanda Javaid, Ahmed A. Elhenawy, Magdi E. A. Zaki, Sajjad Ahmad, Magda H. Abdellattif
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Pharmaceuticals
Subjects:
benzofuran-1,3,4-oxadiazole
tuberclosis
Pks13 inhibitor
molecular docking
MM-PBSA
MD simulations
Online Access:https://www.mdpi.com/1424-8247/16/6/829

Internet

https://www.mdpi.com/1424-8247/16/6/829

Similar Items